VYTRUS BIOTECH

Trading sesion


24/05/2024 Close

2.3800

Last price


16.93 mill. €

Capitalisation

0.85

Dif.(%)


27.96

% Year 2024

Last Trade

Date

24/05/2024

Hour

Close

Last

2.3800

Ref.

2.3600

Dif.(%)

0.85

Volume (Shares)

42,100

Turnover (€x1000)

99.8

X
24/05/2024 15:59:58
BidAsk
OrdersVolumePricePriceVolumeOrders
12,1002.38002.38002,1011

Security

Security name

VYTRUS BIOTECH

Ticker

VYT

ISIN

ES0105618005

NIF

A-65118531

Shares Admitted

7.115.100

Nominal

0,01 Euros

Capital Admitted

71.151,00 Euros

Trading

Fixing

Liquidity Provider

GVC GAESCO VALORES, S.V., S.A.

Registered Advisor

GVC GAESCO VALORES, S.V., S.A.

Auditor

RSM SPAIN AUDITORES S.L.P.

Address

SANT GAIET 121, 08221 TERRASSA, BARCELONA

Contact

investors@vytrus.com

Historical Summary

 202220232024 until 24/05

Capital Admitted (thousands of euros)

717171

Shares (x 1,000)

7,1157,1157,115

Period Close Price (euros)

3.40001.86002.3800

Period Last Price (euros)

3.40001.86002.3800

Period High Price (euros)

4.00003.50002.5000

Period Low Price (euros)

2.06001.78001.8400

Capitalisation (thousands of euros)

24,19113,23416,934

Volume (thousands of shares)

541367632

Turnover (thousands of euros)

1,7659571,435

"Our biotech platform of plant stem cell cultivations creates a new paradigm in dermo-cosmetics: beauty as a consequence of health and not the other way around."

Company Profile

Vytrus Biotech's goal is to be a benchmark in the dermo-cosmetic ingredients sector in innovation and sustainability through our biotechnological platforms of plant stem cell cultures. We promote skin health to improve people's appearance and well-being.

At Vytrus Biotech we develop, produce and market worldwide high value-added active ingredients in the dermo-cosmetic market. Plant stem cell technology has enormous potential not only in dermo-cosmetics but also in other sectors such as veterinary medicine, functional food and pharmaceuticals.

For the first time, technology and nature can be combined in a single product. Vytrus Biotech's biotechnology gives it a competitive advantage over traditional plant extracts. We obtain highly effective, sustainable and safe products, generating savings of more than 99% in natural resources and contributing to the preservation of the planet's biodiversity.

Other Relevant Information

Photo Gallery

To obtain detailed information or information in other formats, please contact BME Market Data at marketdata@grupobme.es or visit the website www.bmemarketdata.es.

The information provided by the different websites of Grupo BME is for internal use only. For any commercial use and/or other usage that involves the redistribution of the information to third parties for a fee, it is required a prior and express permission from BME Market Data. Please contact us at marketdata@grupobme.es.